The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.1533G>A (p.Arg511=)

CA10587278

254695 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 09cb4f93-9073-4758-b6c9-1d4517c0e238

HGVS expressions

NM_000018.4:c.1533G>A
NM_000018.4(ACADVL):c.1533G>A (p.Arg511=)
NC_000017.11:g.7224321G>A
CM000679.2:g.7224321G>A
NC_000017.10:g.7127640G>A
CM000679.1:g.7127640G>A
NC_000017.9:g.7068364G>A
NG_007975.1:g.9488G>A
NG_008391.2:g.730C>T
NG_033038.1:g.15224C>T
ENST00000356839.10:c.1533G>A
ENST00000322910.9:c.*1488G>A
ENST00000350303.9:c.1467G>A
ENST00000356839.9:c.1533G>A
ENST00000542255.6:n.391G>A
ENST00000543245.6:c.1602G>A
ENST00000578319.5:n.28G>A
ENST00000578711.1:n.817G>A
ENST00000578809.5:n.105G>A
ENST00000579391.1:n.141G>A
ENST00000579425.5:n.649G>A
ENST00000579546.1:n.272G>A
ENST00000579894.5:n.320G>A
ENST00000582450.1:n.41G>A
ENST00000583074.5:n.154G>A
ENST00000583850.5:n.308G>A
ENST00000583858.5:n.464G>A
ENST00000585203.6:n.724G>A
NM_000018.3:c.1533G>A
NM_001033859.2:c.1467G>A
NM_001270447.1:c.1602G>A
NM_001270448.1:c.1305G>A
NM_001033859.3:c.1467G>A
NM_001270447.2:c.1602G>A
NM_001270448.2:c.1305G>A

Likely Benign

Met criteria codes 2
BP4 BP7

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1533G>A (p.Arg511=) variant is a synonymous (silent) variant that is not predicted by (SpliceAI, MaxEntScn, NNSplice) to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by the 100 vertebrate Basewise Conservation by PhyloP track in the UCSC genome browser (BP4, BP7). This variant is absent from gnomAD v2.1.1; however, this is not considered conflicting evidence with BP4 and BP7. In summary, this variant meets the criteria to be classified as likely benign for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: BP4, BP7 (ACADVL VCEP specifications version 1; approved November 8, 2021)
Met criteria codes
BP4
The results from 3 in silico splicing predictors (SpliceAI, MaxEntScn, NNSplice) support that this variant does not affect splicing (BP4).
BP7
In addition, it occurs at a nucleotide that is not conserved as shown by the 100 vertebrate Basewise Conservation by PhyloP track in the UCSC genome browser (BP4, BP7).
Approved on: 2022-12-14
Published on: 2022-12-14
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.